Inogen stock faces a strategic reset after rental sale
AD HOC NEWS
Inogen has agreed to sell its U.S. oxygen rental business to Rotech Healthcare for up to $25 million, a strategic divestiture aimed at improving business mix and profitability. The rental unit generated $24.3 million in revenue in the first half of 2026 and will be reported as discontinued operations from Q3 2026. Needham maintains a Buy rating and a $12.00 price target on Inogen stock, suggesting significant upside from its current price after the announced sale.
Read the full story
This is a short summary. The complete article is published by AD HOC NEWS.
Headline and summary aggregated from public news feeds. For information only — not financial advice.